Nestlé Pays $1.4 Billion for Valeant Assets

Nestlé is paying $1.4 billion for the rights to a handful of skin care products from Valeant Pharmaceuticals in a move that will bolster the Swiss food giant's newly established dermatology unit.



from WSJ.com: US Business http://ift.tt/1wjd9UU

via IFTTT